Samarth Kulkarni is the founder of CRISPR Therapeutics. Latest round: IPO. Based in Zug, Switzerland.
Samarth Kulkarni is the President and Chief Business Officer of CRISPR Therapeutics, a biopharmaceutical company focused on developing gene-based therapeutics using its proprietary CRISPR/Cas9 gene-editing platform. The company aims to provide a functional cure for beta thalassemia and sickle cell disease, and has strategic collaborations with Bayer AG and Vertex Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library